Literature DB >> 20447453

A formal analysis of cytokine networks in chronic fatigue syndrome.

Gordon Broderick1, Jim Fuite, Andrea Kreitz, Suzanne D Vernon, Nancy Klimas, Mary Ann Fletcher.   

Abstract

Chronic Fatigue Syndrome (CFS) is a complex illness affecting 4 million Americans for which no characteristic lesion has been identified. Instead of searching for a deficiency in any single marker, we propose that CFS is associated with a profound imbalance in the regulation of immune function forcing a departure from standard pre-programmed responses. To identify these imbalances we apply network analysis to the co-expression of 16 cytokines in CFS subjects and healthy controls. Concentrations of IL-1a, 1b, 2, 4, 5, 6, 8, 10, 12, 13, 15, 17 and 23, IFN-γ, lymphotoxin-α (LT-α) and TNF-α were measured in the plasma of 40 female CFS and 59 case-matched controls. Cytokine co-expression networks were constructed from the pair-wise mutual information (MI) patterns found within each subject group. These networks differed in topology significantly more than expected by chance with the CFS network being more hub-like in design. Analysis of local modularity isolated statistically distinct cytokine communities recognizable as pre-programmed immune functional components. These showed highly attenuated Th1 and Th17 immune responses in CFS. High Th2 marker expression but weak interaction patterns pointed to an established Th2 inflammatory milieu. Similarly, altered associations in CFS provided indirect evidence of diminished NK cell responsiveness to IL-12 and LT-α stimulus. These observations are consistent with several processes active in latent viral infection and would not have been uncovered by assessing marker expression alone. Furthermore this analysis identifies key sub-networks such as IL-2:IFN-γ:TNF-α that might be targeted in restoring normal immune function.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447453      PMCID: PMC2939140          DOI: 10.1016/j.bbi.2010.04.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  61 in total

1.  The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data.

Authors:  G Harper; G S Bravi; S D Pickett; J Hussain; D V S Green
Journal:  J Chem Inf Comput Sci       Date:  2004 Nov-Dec

Review 2.  The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes.

Authors:  Irma Airoldi; Roberta Guglielmino; Giuseppe Carra; Anna Corcione; Franca Gerosa; Giuseppe Taborelli; Giorgio Trinchieri; Vito Pistoia
Journal:  Haematologica       Date:  2002-04       Impact factor: 9.941

3.  A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo.

Authors:  Georgia Perona-Wright; Stephen J Jenkins; Richard A O'Connor; Dimitrios Zienkiewicz; Henry J McSorley; Rick M Maizels; Stephen M Anderton; Andrew S MacDonald
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

5.  Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling.

Authors:  M Samanta; D Iwakiri; K Takada
Journal:  Oncogene       Date:  2008-03-24       Impact factor: 9.867

6.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jonathan R Kerr; Robert Petty; Beverley Burke; John Gough; David Fear; Lindsey I Sinclair; Derek L Mattey; Selwyn C M Richards; Jane Montgomery; Don A Baldwin; Paul Kellam; Tim J Harrison; George E Griffin; Janice Main; Derek Enlander; David J Nutt; Stephen T Holgate
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

Review 7.  From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.

Authors:  Katia Boniface; Bianca Blom; Yong-Jun Liu; René de Waal Malefyt
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

8.  Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.

Authors:  M P Thompson; B B Aggarwal; S Shishodia; Z Estrov; R Kurzrock
Journal:  Leukemia       Date:  2003-11       Impact factor: 11.528

9.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

10.  Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.

Authors:  Anne L Aspler; Carly Bolshin; Suzanne D Vernon; Gordon Broderick
Journal:  Behav Brain Funct       Date:  2008-09-26       Impact factor: 3.759

View more
  92 in total

1.  Sleep and fatigue in mice infected with murine gammaherpesvirus 68.

Authors:  Melissa D Olivadoti; Jason B Weinberg; Linda A Toth; Mark R Opp
Journal:  Brain Behav Immun       Date:  2011-01-24       Impact factor: 7.217

Review 2.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

Review 3.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

4.  Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndrome.

Authors:  Toru Nakamura; Stephan Schwander; Robert Donnelly; Dane B Cook; Felix Ortega; Fumiharu Togo; Yoshiharu Yamamoto; Neil S Cherniack; Marc Klapholz; David Rapoport; Benjamin H Natelson
Journal:  Clin Vaccine Immunol       Date:  2013-09-11

5.  Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy.

Authors:  Tamara S Bodnar; Charlis Raineki; Wladimir Wertelecki; Lyubov Yevtushok; Larisa Plotka; Natalya Zymak-Zakutnya; Gordon Honerkamp-Smith; Alan Wells; Matthieu Rolland; Todd S Woodward; Claire D Coles; Julie A Kable; Christina D Chambers; Joanne Weinberg
Journal:  Brain Behav Immun       Date:  2018-05-05       Impact factor: 7.217

6.  Effectiveness of nasal irrigation for chronic rhinosinusitis and fatigue in patients with Gulf War illness: protocol for a randomized controlled trial.

Authors:  Supriya D Hayer; David P Rabago; Iliya P Amaza; Tony Kille; Christopher L Coe; Aleksandra Zgierska; Larissa Zakletskaia; Marlon P Mundt; Dean Krahn; Chidi N Obasi; Rachel C Molander
Journal:  Contemp Clin Trials       Date:  2015-01-24       Impact factor: 2.226

7.  Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.

Authors:  Matthew C Morris; Katherine E Cooney; Hooman Sedghamiz; Maria Abreu; Fanny Collado; Elizabeth G Balbin; Travis J A Craddock; Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Clin Ther       Date:  2019-03-28       Impact factor: 3.393

8.  Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.

Authors:  A R Light; L Bateman; D Jo; R W Hughen; T A Vanhaitsma; A T White; K C Light
Journal:  J Intern Med       Date:  2011-07-13       Impact factor: 8.989

9.  Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.

Authors:  David Benjamin Fischer; Arsani Hany William; Adam Campbell Strauss; Elizabeth R Unger; Leonard Jason; Gailen D Marshall; Jordan D Dimitrakoff
Journal:  Fatigue       Date:  2014-06-01

10.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.